Advertisement

© 2016

Metabolic Influences on Risk for Tendon Disorders

  • Paul W. Ackermann
  • David A. Hart

Benefits

  • The first book on "Metabolic Tendon Disorders"

  • A comprehensive account of the basic biology of tendons

  • A comprehensive account of the metabolic influences on risk for tendon disorders

Book

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 920)

Table of contents

  1. Front Matter
    Pages i-ix
  2. Basic Biology and Anatomy

    1. Front Matter
      Pages 1-1
    2. Chavaunne T. Thorpe, Hazel R. C. Screen
      Pages 3-10
    3. S. Peter Magnusson, Katja M. Heinemeier, Michael Kjaer
      Pages 11-25
    4. Keitaro Kubo
      Pages 27-33
    5. Paul W. Ackermann, Paul Salo, David A. Hart
      Pages 35-51
    6. James H-C. Wang, Issei Komatsu
      Pages 53-62
    7. Michelle E. Wall, Nathaniel A. Dyment, Josie Bodle, Jon Volmer, Elizabeth Loboa, Anna Cederlund et al.
      Pages 79-95
  3. Tendon Disorders Associated with Altered Metabolism and Metabolic Disorders

    1. Front Matter
      Pages 107-107
    2. Alison September, Masouda Rahim, Malcolm Collins
      Pages 109-116
    3. Michele Abate, Vincenzo Salini, Isabel Andia
      Pages 117-122
    4. Isabel Andia, Michele Abate
      Pages 123-132
    5. Francesco Oliva, Eleonora Piccirilli, Anna C. Berardi, Umberto Tarantino, Nicola Maffulli
      Pages 133-138
    6. Mette Hansen, Michael Kjaer
      Pages 139-149
    7. Louis J. Soslowsky, George W. Fryhofer
      Pages 151-165
    8. Michele Abate, Vincenzo Salini, Isabel Andia
      Pages 167-177
    9. Aisha Siddiqah Ahmed
      Pages 179-184
    10. Bento João Abreu, Wouber Hérickson de Brito Vieira
      Pages 185-190

About this book

Introduction

This book will be of considerable interest to students, practitioners (Doctors, Physiotherapists, and other health care professionals), and researchers who deal with the complex structure of tendons and the need to effectively address tendon disorders. The book is divided into three sections: (1) Basic Biology and Biochemical Markers; (2) Metabolic Disorders; and (3) Novel Therapies. The first section, devoted to the basic biology of tendons, is aimed at those individuals who want to gain basic information on tendons and the subsection on biochemical markers is chiefly aimed at researchers who are developing new studies within this field. The section on metabolic disorders is mainly directed at practitioners who desire to know how metabolic disorders can affect tendons in order to optimize treatment for their patients. Finally, the section on novel therapies is focused on some new treatment options within this field, and discussions regarding how management of tendon disorders needs to incorporate perspectives on current understanding of tendon metabolism. 

Keywords

Basic Biology Human Physiology Metabolic Disorders Tendinopathy Tendons

Editors and affiliations

  • Paul W. Ackermann
    • 1
  • David A. Hart
    • 2
  1. 1.Department of Molecular Medicine and SurgeryKarolinska InstitutetStockholmSweden
  2. 2.McCaig Institute for Bone and Joint HealthUniversity of CalgaryCalgaryCanada

Bibliographic information

  • Book Title Metabolic Influences on Risk for Tendon Disorders
  • Editors Paul W. Ackermann
    David A. Hart
  • Series Title Advances in Experimental Medicine and Biology
  • Series Abbreviated Title Adv Exp Med Biol
  • DOI https://doi.org/10.1007/978-3-319-33943-6
  • Copyright Information Springer International Publishing Switzerland 2016
  • Publisher Name Springer, Cham
  • eBook Packages Biomedical and Life Sciences Biomedical and Life Sciences (R0)
  • Hardcover ISBN 978-3-319-33941-2
  • Softcover ISBN 978-3-319-81637-1
  • eBook ISBN 978-3-319-33943-6
  • Series ISSN 0065-2598
  • Series E-ISSN 2214-8019
  • Edition Number 1
  • Number of Pages IX, 304
  • Number of Illustrations 45 b/w illustrations, 48 illustrations in colour
  • Topics Human Physiology
    Medicine/Public Health, general
  • Buy this book on publisher's site
Industry Sectors
Biomedicine
Biotechnology
Health & Hospitals
Pharma